Kolwelter Julie, Uder Michael, Schmieder Roland E
Department of Nephrology and Hypertension.
Department of Cardiology.
J Hypertens. 2020 Dec;38(12):2363-2368. doi: 10.1097/HJH.0000000000002580.
: Most textbooks state that sodium (Na) accumulation goes hand in hand with fluid retention to maintain the environmental isotonicity. In the last century, several studies found, however, that Na is stored in the extravascular space leading to an activation of the monocyte phagocytic system cells that work as a regulator of the interstitial electrolyte homeostasis. Na-MRI was developed to quantify noninvasively, accurately and reliably tissue Na content. In this review, we give an up-to-date overview of clinical studies utilizing this Na-MRI technique to elucidate the importance of tissue Na content in patients with cardiovascular risk factors leading to microvascular and macrovascular complications. Na storage leads ultimately to organ damage such as left ventricular hypertrophy or hypertrophic vascular remodeling of resistance vessels. Elevated Na content in muscle and skin has been detected in patients with treatment resistant hypertension, type 2 diabetes mellitus, acute and chronic heart failure, chronic kidney disease and end-stage renal failure. Pharmacological interventions have shown that a mobilization of extracellular accumulated Na is possible and may emerge as a new therapeutic approach in some diseases.
大多数教科书指出,钠(Na)的蓄积与液体潴留相伴发生,以维持环境等渗性。然而,在上个世纪,多项研究发现,钠储存在血管外间隙,导致单核细胞吞噬系统细胞被激活,这些细胞作为间质电解质稳态的调节因子发挥作用。钠磁共振成像(Na-MRI)技术的开发是为了无创、准确且可靠地定量组织钠含量。在本综述中,我们对利用这种Na-MRI技术的临床研究进行了最新概述,以阐明组织钠含量在导致微血管和大血管并发症的心血管危险因素患者中的重要性。钠的储存最终会导致器官损伤,如左心室肥厚或阻力血管的肥厚性血管重塑。在难治性高血压、2型糖尿病、急慢性心力衰竭、慢性肾脏病和终末期肾衰竭患者中,已检测到肌肉和皮肤中的钠含量升高。药物干预表明,动员细胞外蓄积的钠是可能的,并且可能成为某些疾病的一种新的治疗方法。